Recently, a non-synonymous CITED2 mutation, p.Pro101Ser, identified in a patient with CHD, was shown to increase CITED2 transcriptional activity at several downstream target genes important for cardiac development, likely due to an altered phosphorylation pattern of the mutant protein [109]. This evidence concerns the gene CITED2 and coronary artery disorder.